当前位置:
首页 > 技术文章 > 黄杨碱 分析标准品,T≥99%
目录导航 Directory
技术支持Article
黄杨碱 分析标准品,T≥99%
点击次数:67 更新时间:2025-12-08

黄杨碱

分析标准品,T≥99%

Cyclovirobuxine

CAS号:860-79-7

分子式:C26H46N2O

分子量:402.66

MDLMFCD00468040

货号

规格/参数/品牌

价格

货期

YJ-B20573-20mg

分析标准品,T≥99%

300.00

现货

JS31427-1g

≥98%

924.00

现货

JS31427-5g

≥98%

2324.00

现货

JS31427-25g

≥98%

5550.00

2-3

JS31427-100g

≥98%

13000.00

2-3

产品介绍

熔点:218-220℃

沸点:495.7 ℃ at 760 mmHg

外观:无色针状结晶

溶解性:在氯仿中易溶,在甲醇或乙醇中溶解,在丙tong中略溶,在水中微溶。

储存条件:2-8℃

注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献(7)

7. [IF=10.7] Yingying Shao et al."Targeting LIF With Cyclovirobuxine D to Suppress Tumor Progression via LIF/p38MAPK/p62-Modulated Mitophagy in Hepatocellular Carcinoma."MedComm.2025 May;6(6):e70227

6. [IF=4.9] Yun-Hao Ren et al."Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D."Pharmaceutics.2024 Dec;16(12):1600

5. [IF=3.1] Gao Ke et al."Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2025 Jan;:1-19

4. [IF=6.8] Yiman Liu et al."Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis."BRITISH JOURNAL OF PHARMACOLOGY.2024 Jul;:

3. [IF=5] Ke Gao et al."DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest."Translational Oncology.2023 Sep;35:101708

2. [IF=3.417] Lingqi  Zhou et al."Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma."Oncol Rep. 2020 Mar;43(3):807-816

1.  增夏,关怀敏,王贺,邱承杰,赵亚楠,曹英杰,解金红.环维黄杨星DH_2O_2损伤大鼠心房肌细胞L型钙通道的影响[J].广东医学,2020,41(16):1631-1636.



沪公网安备 31011802001678号